ARWR vs AWK · rev $829.4M vs P/E 22, rev $4.65B
Arrowhead Pharmaceuticals Inc (ARWR) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ARWR currently screens at market cap $10.59B. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ARWR and AWK stock pages for the full models.
Not investment advice.